TDAM USA’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,281
Closed -$485K 428
2014
Q4
$485K Buy
2,281
+708
+45% +$141K 0.02% 241
2014
Q3
$280K Buy
1,573
+60
+4% +$9.96K 0.01% 277
2014
Q2
$256K Sell
1,513
-817
-35% -$127K 0.01% 292
2014
Q1
$289K Buy
2,330
+33
+1% +$4.02K 0.01% 288
2013
Q4
$255K Buy
+2,297
New +$219K 0.01% 286
2013
Q3
Sell
-3,183
Closed -$317K 359
2013
Q2
$317K Buy
+3,183
New +$330K 0.01% 225

Other funds holding AGN

TDAM USA's AGN Position: Q1 2015 in Review

TDAM USA sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,281 shares — an estimated $485K sold.

TDAM USA first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $485K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • TDAM USA reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • TDAM USA sold 2,281 Allergan Inc shares in Q1 2015, an estimated $485K.
  • TDAM USA first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • TDAM USA's Allergan Inc position peaked at $485K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on TDAM USA's 13F filing for Q1 2015, filed 28 Apr 2015.